Evaluation of Treatment Interval Extension and Short-Term Interval Stability after Switching to Faricimab in Neovascular AMD: A Mid-Term Observational Study.
- DOI
- 10.1159/oph/aeeag007
- Published
- 2026 Aug 7
- Container
- Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1159/oph/aeeag007,
title = {Evaluation of Treatment Interval Extension and Short-Term Interval Stability after Switching to Faricimab in Neovascular AMD: A Mid-Term Observational Study.},
author = {Simond B and Fenniri I and Chirpaz N and Elbany S and Rocher A and Gilli C and Chacun S and Voirin N and Burillon C and Matagrin B and Dot C},
year = {2026},
journal = {Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde},
doi = {10.1159/oph/aeeag007},
url = {https://doi.org/10.1159/oph/aeeag007}
}RIS
TY - JOUR TI - Evaluation of Treatment Interval Extension and Short-Term Interval Stability after Switching to Faricimab in Neovascular AMD: A Mid-Term Observational Study. AU - Simond B AU - Fenniri I AU - Chirpaz N AU - Elbany S AU - Rocher A AU - Gilli C AU - Chacun S AU - Voirin N AU - Burillon C AU - Matagrin B AU - Dot C PY - 2026 JO - Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde DO - 10.1159/oph/aeeag007 UR - https://doi.org/10.1159/oph/aeeag007 ER -
APA
B, S., I, F., N, C., S, E., A, R., C, G., S, C., N, V., C, B., B, M., & C, D. (2026). Evaluation of Treatment Interval Extension and Short-Term Interval Stability after Switching to Faricimab in Neovascular AMD: A Mid-Term Observational Study.. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde. https://doi.org/10.1159/oph/aeeag007
Source records
- pubmed · retrieved 2026-09-26T19:54:29.583Z